New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
09:31 EDTROSGRosetta Genomics receives final NY approval for its kidney cancer test
Rosetta Genomics announced that the New York State Department of Health has given the company final approval for its Rosetta Kidney Cancer Test for testing on patient samples from the State. Rosetta Genomics has been offering its Kidney Cancer Test in New York under conditional approval since December 9, 2013 and now has full approval in all 50 U.S. states. The Kidney Cancer Test is the company's proprietary microRNA-based assay that can classify the four most common kidney tumors: Clear Cell Renal Cell Carcinoma, Papillary RCC, Chromophobe RCC and Oncocytoma. With this final approval, each of Rosetta's cancer testing services now has full New York State approval.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
18:29 EDTROSGOn The Fly: After Hours Movers
Subscribe for More Information
18:15 EDTROSGRosetta Genomics up nearly 9% after-hours following earnings report
18:12 EDTROSGRosetta Genomics reports 1H14 EPS (62c) vs (64c) last year
The company reported 1H14 revenues $0.55M vs $0.19M last year.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use